Table 3.
Baseline clinical characteristics stratified by subjective outcomes.
| Good Outcome (N = 71) | Poor Outcome (N = 35) | p | |
|---|---|---|---|
| Age | 61.5 ± 18.9 | 62.4 ± 21.3 | 0.814 |
| HT | 28 (39%) | 14 (39%) | 0.956 |
| DM | 24 (34%) | 8 (22%) | 0.216 |
| CKD | 4 (6%) | 2 (6%) | 1.000 |
| COPD | 2 (3%) | 1 (3%) | 1.000 |
| CAD | 5 (7%) | 2 (6%) | 1.000 |
| Neurogenic history a | 35 (49%) | 15 (42%) | 0.455 |
| Catheterization b | 20 (28%) | 22 (61%) | 0.001 * |
| DV | 15 (21%) | 8 (23%) | 0.839 |
| DSD | 15 (21%) | 5 (14%) | 0.397 |
| PRES | 41 (58%) | 22 (63%) | 0.614 |
| DO | 26 (37%) | 12 (33%) | 0.737 |
| DU | 29 (41%) | 16 (44%) | 0.722 |
| DHIC | 9 (13%) | 5 (14%) | 1.000 |
| Narrow BN | 6 (9%) | 29 (81%) | <0.001 * |
| UFR parameters | |||
| Qmax | 7.3 ± 4.7 | 5.8 ± 4.4 | 0.096 |
| Voiding volume | 129.5 ± 103.7 | 109.5 ± 85.3 | 0.327 |
| PVR (≥230 mL) | 17 (24%) | 20 (56%) | 0.001 * |
| CBC (≥350 mL) | 21 (30%) | 22 (61%) | 0.002 * |
| VE | 0.44 ± 0.26 | 0.35 ± 0.27 | 0.089 |
| vUDS parameters | |||
| FSF | 148.4 ± 92.2 | 118.7 ± 56.7 | 0.080 |
| FS | 218.7 ± 107.0 | 187.6 ± 84.0 | 0.130 |
| US | 251.4 ± 120.9 | 215.8 ± 99.4 | 0.130 |
| Compliance | 78.6 ± 116.3 | 58.1 ± 72.0 | 0.335 |
| Pdet | 28.9 ± 29.6 | 22.8 ± 24.0 | 0.285 |
| Qmax | 5.7 ± 5.1 | 4.2 ± 3.7 | 0.095 |
| BOOI | 17.6 ± 30.7 | 14.4 ± 25.6 | 0.567 |
| PVR | 226.8 ± 178.5 | 279.4 ± 190.2 | 0.162 |
| CBC | 339.9 ± 172.1 | 372.2 ± 189.3 | 0.376 |
| VE | 0.35 ± 0.30 | 0.27 ± 0.22 | 0.090 |
BN: bladder neck, BOOI: bladder outlet obstruction index, CAD: coronary artery disease, CBC: cystometric bladder capacity, CKD: chronic kidney disease, COPD: chronic obstructive lung disease, DM: diabetes mellitus, DO: detrusor overactivity, DHIC: detrusor hyperactivity with impaired contractility, DSD: detrusor sphincter dyssynergia, DU: detrusor underactivity, DV: dysfunctional voiding, HT: hypertension, FS: full sensation, FSF: the first sensation of filling, Pdet: detrusor pressure at the maximum flow rate, PRES: poor relaxation of the external sphincter, PVR: post-void residual volume, Qmax: the maximal flow rate, UFR: uroflowmetry, US: urge sensation, VE: voiding efficiency, vUDS: video-urodynamic studies. a Diabetes was included in neurogenic history. b Catheterization included clean intermittent catheterization, Foley, or cystostomy. * p < 0.05.